Bladder Cancer Trial, Recruiting NCT06396533 Sponsor: Fox Chase Cancer Center Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06396533
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a high-grade early-stage bladder tumor (called high grade T1) and, after being fully informed of your options, have chosen to have your bladder removed.
  • You have a non-invasive high-grade bladder tumor or pre-cancerous cells in the bladder lining that have not responded to treatment placed directly into the bladder, and you have chosen to have your bladder removed.
  • You have bladder cancer that has grown into the muscle wall of the bladder (stage T2 or T3) and are planned to have your bladder removed.
  • You have previously had bladder treatments such as medication placed directly into the bladder, or one or more procedures to remove bladder tumors, and can still join (details about these past treatments will be recorded).
  • You are male or female and are 18 years of age or older at the time you give your consent to join.
  • You are willing and able to follow all the requirements of the study.
  • You have had, or are able to get, a specific type of CT scan (without contrast dye) of your chest, abdomen, and pelvis either before or during the screening process.
  • If you need chemotherapy or other drug treatment before your bladder removal surgery, you must join the study before that treatment begins.
  • You are able to understand the study and are willing to sign a consent form agreeing to take part.

Who may not be able to join:

  • You are having your bladder removed for reasons other than trying to cure your cancer (for example, for comfort or symptom relief only).
  • You have already had radiation treatment directed at the pelvis area specifically to treat bladder cancer.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Kutikov, M.D., Fox Chase Cancer Center

Phone: 215-728-3096

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fox Chase Cancer Center
Registry
ClinicalTrials.gov
Start date
13 August 2024
Est. completion
23 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Utility of a proprietary urine and blood biomarker test for muscle-invasive bladder cancer presence; Utility of a DNA test for muscle-invasive bladder cancer presence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov